Datos Health
- Industry
- Health Care Technology
- Founded Year
- 2015
- Headquarters
- 333 W 52nd St Ste 1208, New York City, New York, 10019, United States
- Employee Count
- 41
Key People
- Uri Bettesh - CEO & Co-founder
- Hylton Peimer - CTO
- Yael Belkin - VP Product
- Omri Hayet - Chief Operating Officer
- Ruthie Weitz-Leopold - Chief Marketing Officer
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises experienced professionals with significant industry experience.
The leadership team, including CEO Uri Bettesh and CTO Hylton Peimer, brings over a decade of experience in healthcare technology, enhancing the company's strategic direction and operational execution.
- Clinical Need
-
Aspect: Very Strong
Summary: The platform addresses a critical need for scalable remote patient monitoring solutions.
With the increasing demand for remote healthcare solutions, Datos Health's platform meets a vital need by enabling healthcare providers to implement and scale remote patient monitoring and virtual care programs effectively.
- Competition
-
Aspect: Somewhat crowded
Summary: The market has several players offering remote patient monitoring solutions.
While the demand for remote patient monitoring is high, the presence of multiple competitors requires Datos Health to differentiate its offerings to capture market share effectively.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing and maintaining a robust, scalable platform presents moderate technical challenges.
Ensuring seamless integration with various healthcare systems and devices, while maintaining data security and compliance, presents moderate technical challenges that require careful management.
- Patent
-
Aspect: Applied
Summary: The company has applied for patents to protect its technology.
By applying for patents, Datos Health aims to protect its intellectual property, which can serve as a barrier to entry for competitors and enhance the company's valuation.
- Financing
-
Aspect: Medium
Summary: The company has raised $7 million in funding over two rounds.
While the $7 million raised provides a solid foundation, further investment may be necessary to support product development, market expansion, and operational scaling.
- Regulatory
-
Aspect: 510k/PMA
Summary: The platform requires regulatory approvals for deployment in healthcare settings.
Obtaining necessary regulatory approvals, such as FDA 510(k) clearance or PMA, ensures compliance with healthcare standards, facilitating adoption by healthcare providers and institutions.
Opportunity Rollup
- Odds of Success
- 3.85
- Peak Market Share
- 5.2
- Segment CAGR
- 3.6%
- Market Segment
- Patient Monitoring
- Market Sub Segment
- Remote Patient Monitoring
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.26 |
| 2 | 0.78 |
| 3 | 1.82 |
| 4 | 3.64 |
| 5 | 5.20 |
Key Takeaway
Datos Health is well-positioned in the growing remote patient monitoring market, but must navigate a competitive landscape and secure additional funding to scale effectively.